For the readers interested in the stock health of Chembio Diagnostics Inc. (CEMI). It is currently valued at $6.34. When the transactions were called off in the previous session, Stock hit the highs of $5.58, after setting-off with the price of $5.47. Company’s stock value dipped to $5.34 during the trading on the day. When the trading was stopped its value was $5.39.
Recently in News on January 14, 2021, Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems. Enters Exclusive U.K. and Ireland Distribution Agreement with Luas Diagnostics. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Chembio Diagnostics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.35 on 01/14/21, with the lowest value was $4.64 for the same time period, recorded on 01/04/21.
Chembio Diagnostics Inc. (CEMI) full year performance was 29.57%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Chembio Diagnostics Inc. shares are logging -60.10% during the 52-week period from high price, and 181.77% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.25 and $15.89.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1929803 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Chembio Diagnostics Inc. (CEMI) recorded performance in the market was 13.47%, having the revenues showcasing 13.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 107.26M, as it employees total of 295 workers.
Analysts verdict on Chembio Diagnostics Inc. (CEMI)
During the last month, 1 analysts gave the Chembio Diagnostics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.94, with a change in the price was noted +1.23. In a similar fashion, Chembio Diagnostics Inc. posted a movement of +24.25% for the period of last 100 days, recording 1,908,957 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CEMI is recording 0.54 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.54.
Chembio Diagnostics Inc. (CEMI): Technical Analysis
Raw Stochastic average of Chembio Diagnostics Inc. in the period of last 50 days is set at 60.80%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 97.08%. In the last 20 days, the company’s Stochastic %K was 74.31% and its Stochastic %D was recorded 57.30%.
Let’s take a glance in the erstwhile performances of Chembio Diagnostics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 13.47%. Additionally, trading for the stock in the period of the last six months notably improved by 5.69%, alongside a boost of 29.57% for the period of the last 12 months. The shares increased approximately by 8.89% in the 7-day charts and went up by -8.64% in the period of the last 30 days. Common stock shares were driven by 13.24% during last recorded quarter.